This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Ribavirin
From Proteopedia
| Line 1: | Line 1: | ||
| - | + | 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide (http://www.rxlist.com/rebetol-drug.htm) | |
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | ||
This is a default text for your page '''Ribavirin'''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. | This is a default text for your page '''Ribavirin'''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. | ||
| Line 20: | Line 20: | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
| - | < | + | <Gish, R. G. (2005, November 17). Treating HCV with ribavirin analogue and ribavirin-like molecules. Journal of Antimicrobial Chemotherapy, 1-6. doi:10.1093/jac/dki405> |
Revision as of 01:23, 16 November 2016
1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide (http://www.rxlist.com/rebetol-drug.htm)
| |||||||||||
References
<Gish, R. G. (2005, November 17). Treating HCV with ribavirin analogue and ribavirin-like molecules. Journal of Antimicrobial Chemotherapy, 1-6. doi:10.1093/jac/dki405>
Proteopedia Page Contributors and Editors (what is this?)
Jamie Costa, Edmond R Atalla, Katherine Reynolds, Taylor H. Derby, Shannon Shaughnessy, Alexander Berchansky
